Previous studies have shown that human T h 2 cells, unlike their murine counterparts, retain the ability to produce IFN-y upon activation in the presence of exogenous IL-12. Here we first extended this notion by showing that T h
Introduction
The protective value of the immune response is largely determined by the spectrum of cytokines produced by T helper cells. In animal models as well as in humans, the majority of CD4 helper T cells fall into three categories differing by the types of cytokines they produce: (i) T h 1 cells produce IL-2, IFN-y and lymphotoxin but not IL-4 or IL-5, (ii) T h 2 cells produce IL-4, IL-5 but not IFN-Y, and (iii) T h 0 cells produce both T h 1-and T h 2-associated cytokines (1) . Although these subsets of T helper cells are derived from the same precursors, they display distinct regulatory and effector functions, and, most importantly, the inappropriate selection of T h 1 or T h 2 effectors may result in ineffective or disease-promoting immune responses (1, 2) . There is compelling evidence that the development of T h 2-rather than T h 1/T h 0-dominated responses to innocuous and ubiquitous airborne or food antigens leads to the development of atopic diseases (2) (3) (4) (5) (6) . The finding that allergen-specific T h 2 cells play a causative role in allergic diseases has prompted several investigations in the animal as well as in the human systems, aiming to identify the factors regulating their development and their effector functions. The latter studies revealed some significant differences between mouse and human T h 2 cells. Mouse T h 2 cells are characterized not only by their ability to produce high levels of type 2 cytokines (IL-4 and IL-5) but also by their failure to produce type 1 cytokines (IL-2 and IFN-y) regardless of their mode of activation (1) . In particular, these cells are unresponsive to IL-12, a potent inducer of IFN-y production (7) . In contrast, human T h 2 cells retain the capacity of secreting high levels of IFN-Y and IL-2 when adequately stimulated, including with phorbol esters plus calcium iono-phore, modified peptide antigen, antigen + anti-SLAM mAb and anti-CD3 + IL-12 (8) (9) (10) (11) (12) (13) , explaining why they are often referred to as Th2-like cells. Additionally, cytokine production by human but not by mouse T h 2 cells is IL-2-dependent and it is increased by B7 co-stimulation (14, 15) .
Initially known as a factor stimulating NK cells and enhancing lymphocyte cytotoxic activity, IL-12 was shown to be an important regulatory cytokine which promotes the development of T h 1 effectors and induces or enhances IFN-y production by resting or activated NK cells and T cells. IL-12 is produced by poly-or mononuclear phagocytes in response to several microbes or their soluble products (16) . More recent studies have further shown that professional antigen-presenting cells (APC) may release IL-12 upon antigen presentation to various T cell subsets, including T h 0, T h 1 and naive cells (17, 18) . IL-12 is also released during non-cognate IL-2-driven interactions between resting peripheral blood T cells and autologous APC (19, 20) . In each case, T cell-induced IL-12 production was shown to depend upon the interaction of CD40L on T cells with CD40 on APC (17, 20, 21) .
The finding that various T cell subsets (T h 1, T h 0 and naive T cells) may induce IL-12 production by APC, together with the fact that T h 2-like cells respond to IL-12, prompted us to examine whether T h 2 cell clones are also capable of inducing IL-12 production. We found that IL-2-or anti-CD3-stimulated T h 2-like clones induced IL-12 production by dendritic cells (DC) but not by monocytes; most interestingly these studies further revealed that T h 2-like clones could express four distinct patterns of cytokines, depending upon the activation signal and the type of APC with which they interacted.
Methods

Reagents
Mouse anti-human CD3 mAb UCHT-1 was kindly provided by Dr P. Beverley (University College and Middlesex School of Medicine, London, UK), goat anti-human IL-12 and human recombinant IL-12 were received from Dr M. Gately (Hoffmann-La Roche, Nutley, NJ), negative control mAb (normal goat IgG) was from Cedarlane (Hornby, Ontario, Canada). Human recombinant IL-2 was kindly received from Dr D. Bron (Institut Bordet, Brussels, Belgium), neutralizing anti-IL-4R mAb (clone 230) was obtained from R & D Systems (Minneapolis, MN).
Cell lines
The mouse L fibroblast cell line co-expressing human CD32 and B7-1 antigens (CD32-B7 L cells) was the same as in our previous studies (22) . The stable T h 2-like cell clones have recently been described; they were obtained by limiting dilution cloning of naive neonatal or adult CD4 T cells on CD32-B7 L cells in the presence of anti-CD3 and IL-2 (23). They were maintained and propagated by repetitive cycles of stimulation with anti-CD3 immobilized on CD32-B7 L cells followed by IL-2 expansion, as reported (22) .
Purification of monocytes and DC
Enriched monocyte (EM) preparations were obtained by aggregation of peripheral blood mononuclear cells in the cold as described (19) 
Cytofluorometric analysis
Cellular preparations were stained with optimal concentration of phycoerythrin-or FITC-conjugated mAb in the presence of normal human Ig. Phycoerythrin-conjugated mAb to CD14 HLA-DR, CD3, CD19, CD56, FITC-conjugated mAb to CD11a and all isotype-matched negative control mAb were purchased from Becton Dickinson (Mountain View, CA). Biotinylated mAb 89 to CD40 was provided by Dr J. Banchereau, (Schering-Plough, Dardilly, France). FITC-conjugated mAb to CD86 and phycoerythrin-conjugated streptavidin were obtained from Ancell (London, Ontario, Canada). After staining, cells were analyzed with a FACScan (Becton Dickinson).
Culture conditions
All cultures were performed in serum-free HB101 medium (Irvine Scientific, Santa Ana, CA) supplemented with 2 mM glutamine, 1 mM sodium pyruvate, 10 mM HEPES, 100 IU penicillin and 100 mg/ml streptomycin. CD4 T cell clones (0.5X10 6 cells/ml) were cultured together with EM (0.5x10 6 cells/ml), CD14 + monocytes (0.5x10 6 cells/ml) or DC (0.25x10 6 cells/ml), in the presence or absence of rlL-2 (50 U/ml), IL-12 (60 pM), anti-CD3 (200 ng/ml), goat antihuman IL-12 or normal goat Ig (5 ng/ml). Cultures were performed in 24-well plates (Falcon; Becton Dickinson) in 1 ml culture medium. After 24 h of culture, 500 ml of supernatant fluid was collected for the measurement of IL-4, IL-5 and IL-12 (p40); IFN-y production was measured after 3 days of culture.
Lymphokine measurements
IFN-y and IL-5 were measured as described (22) by sandwich solid-phase radioimmunoassay using anti-human IFN-y mAb (clone 4225) and anti-human IL-5 (clone 4H8) to coat the solid phase and 125 l-labeled anti-human-IFN-y mAb (clone 45.15) or anti-human IL-5 (clone 5A5). IL-12 p40 was detected by a two-site sandwich ELISA employing clone 2-4A1 as capture mAb and clone 9D6 as second mAb (17) . IL-4 was measured by ELISA as previously described (22) . These assays were sensitive at 30 pg/ml for IFN-y, 150 pg/ml for IL-4 and IL-5, and 6 pg/ml for IL-12 p40. 
Results
The profile of cytokines released by T h 2-like clones depends upon their mode of activation and the presence of accessory cells
The T cell clones employed in the present studies displayed the typical phenotypic and functional features of T h 2-like cells in that: (i) they were >99% CD4+ CD45R0 bri 9 ht and >70% CD30 + , (ii) they induced IgE synthesis by purified resting B cells (22) , and (iii) on stimulation with anti-CD3 cross-linked to CD32-B7 L cells, they produced high levels of IL-4 and IL-5 but no or little (<0.5 ng/ml) IFN-y (Fig. 1 ). When stimulated with anti-CD3 in the presence of physiological APC, i.e. EM preparations, instead of CD32-B7 L cells, the T cell clones produced significant amounts of IFN-y and the same levels of IL-4 and IL-5. The possibility that IFN-y was derived from T cells or NK cells contaminating EM was unlikely given that (i) EM produced <1 ng/ml of IFN-y (range 0-0.7) when cultured with IL-2 (50 U/ml) plus IL-12 (60 pM) and (ii) EM contained no detectable (<1%) CD3 + or CD56 + cells. Further to the previous report that IL-2 induces IL-12 and IFN-y production in co-cultures of resting peripheral blood T cells and autologous monocytes (19) , T h 2-like clones were examined for cytokine production during co-culture with EM in the presence of IL-2. As seen, these cultures released the same levels of IFN-y as those stimulated with anti-CD3 mAb, they also contained significant amounts of IL-5 but no IL-4. IL-4 remained undetectable in two additional experiments in which IL-2-stimulated cultures were supplemented with anti-IL-4R mAb (2.5 ng/ml), arguing against the possibility that low levels of this cytokine were produced and immediately used by T h 2C. It is of note that in the absence of IL-2, EM did not induce detectable cytokine production by T h 2C, whereas, in the absence of EM, IL-2 induced only the production of small amounts of IL-5 (<2 ng/ml) but not of IL-4 or IFN-y.
IFN-y production by T cell clones is IL-12-dependent
Since IL-12 is a very potent inducer of IFN-y, we examined whether the IFN-y production observed in cultures of T h 2C + EM was IL-12-dependent. Neutralizing anti-IL-12 antibody inhibited by 80% the production of IFN-y by T cell clones stimulated with anti-CD3 or IL-2 (Fig. 2) . Anti-IL-12 antibody had little effect on the production of IL-4 or IL-5 and, more particularly, it did not permit the production of IL-4 by T h 2C cocultured with EM + IL-2. To determine whether endogenously produced IL-12 was sufficient to induce IFN-y production, T cell clones were cultured with CD32-B7 L cells and IL-2 in the presence or absence of IL-12. Exogenous IL-12 induced IFN-y production by T h 2C stimulated with anti-CD3 but not with IL-2 ( Table 1 ). The failure of CD32-B7 L fibroblasts to support IFN-y production in response to exogenous IL-2 + IL-12 indicated that EM exerted a dual role in inducing IFN-y production in response to IL-2: (i) they produced endogenous IL-12, and (ii) they provided an additional co-stimulatory signal distinct from B7-1 and which was necessary to support the response of T h 2C to IL-2 + IL-12.
Cellular origin of IL-12
The above observations revealed that T h 2 clones responded to IL-12 and that they were capable of inducing IL-12 produc-A. EM+aCD3 
T cells (0.5xi0 6 /ml) were co-cultured with either positively selected CD14 + monocytes (0.5xi0 6 /ml) or irradiated CD32-B7L cells (0.25X10 6 / ml) in the presence or absence of anti-CD3, IL-2 and IL-12 as indicated. The data correspond to mean ± SDof n experiments (in parentheses). <, not detected. tion by EM. To examine the cellular origin of IL-12 produced in co-cultures of T h 2C + EM, the latter were fractionated into (i) highly purified monocytes, obtained by positive selection of CD14+ cells (>99% CD14 bri 9 ht ), (ii) EM depleted of CD14+ cells and (iii) DC. These were isolated from EM preparations by negative selection as detailed in Methods. Phenotypically, they were >95% HLA DR br '9 ht and <1% CD14 br '9 ht , CD20 + , CD56 + or CD3 + ; they expressed variable levels of CD40 and CD86 (Fig. 3) . After 4 days of stimulation with IL-2 + IL-12, they produced no or little IFN-y (<0.5 ng/ml). These various cellular preparations were compared for their ability to induce IFN-y production by T h 2C and to produce IL-12 p40 when co-cultured with T h 2C. As seen (Fig. 4) , EM, EM-depleted of monocytes and DC induced IFN-y production by T h 2C stimulated either with anti-CD3 or with IL-2; however, purified monocytes failed to do so, in spite of the fact that they supported IL-4 and IL-5 production by anti-CD3-stimulated cells. Monocytes were also capable to support significant production of IL-5 in response to IL-2. The data in Table 2 revealed that: (i) EM and DC but not monocytes released IL-12 p40 when cultured in the presence of T h 2C, and (ii) the production of IL-12 was markedly increased by IL-2. Interestingly, higher levels of p40 were observed in the absence than in the presence of anti-CD3 stimulation. This should be related to the production of IL-12 inhibitors, i.e. IL-4 and IL-10, by anti-CD3 but not by IL-2-stimulated T h 2C. Indeed, addition of anti-IL-4R (2.5 mg/ml) + anti-IL-10 mAb (10 ng/ml) resulted in a significant enhancement of IL-12 production in anti-CD3-stimulated EM + T h 2C cultures (25 versus 310 pg/ml of IL-12 p40, in two experiments) but not in IL-2-stimulated cultures (270 versus 295 pg/ml). That the inability of monocytes to support IFN-y production by T h 2C resulted only from their failure to produce IL-12 was supported by the finding that in the presence of exogenous IL-12, monocytes were capable of supporting IFN-yproduction in response to anti-CD3 as well as IL-2 ( Fluorescence intensity 92.2 ± 64.3 (7) T + monocyte + anti-CD3 + IL-2 < (7) T + EDC + anti-CD3 + IL-2 47.1 ± 21.5
T cell clones (0.5xi0 6 /ml) were cultured together with either EM, CD14+ monocytes (each at O.5xiO 6 /ml) or DC (0.25xi0 6 /ml) in the presence of either IL-2, anti-CD3 or IL-2 + anti-CD3. Culture supematants were collected after 24 h and IL-12 p40 was measured by ELISA. The data correspond to mean ± SD of n experiments (in parentheses). <, not detectable.
CD32-B7 L cells, monocytes provided a co-stimulatory signal enabling T h 2C to respond to IL-12 in the absence of anti-CD3 stimulation.
Discussion
In the present study we have shown that human T h 2-like cell clones are capable of inducing IL-12 production by physiological APC and that the profiles of cytokine they produce may be more heterogenous than initially thought. Every T cell clone examined in the present study could be induced to express exactly the same four cytokine profiles as those displayed by T cell clones derived from the lesional skin of patients with atopic dermatitis (24) . Depending upon the activation signal (anti-CD3 or IL-2) and the type of APC with which they interacted (monocytes or DC), each T cell clone could be stimulated to produce either (i) IL-4 + IL-5, Ligation of CD3 was necessary to induce IL-4 production, whereas DC were required to trigger IFN-y production. In response to anti-CD3 stimulation, T h 2C produced high levels of IL-4 and IL-5, regardless of the type of accessory cells present in the cultures; in contrast, IFN-y was released only in cultures containing either EM, EM depleted of monocytes or DC, but not in cultures containing highly purified monocytes. The production of IFN-Y i n response to anti-CD3 or IL-2 was secondary to the ability of T h 2C to induce the release of IL-12 by DC. Indeed, it was suppressed by anti-IL-12 neutralizing antibody and IL-12 p40 was detected in the supernatant fluids of cultures containing T h 2C + DC but not T h 2C + monocytes. The levels of IL-12 released in IL-2-stimulated cultures were much higher than those induced by anti-CD3 (Table 2) , presumably because IL-2, unlike anti-CD3, did not induce the production of IL-12 inhibitors, i.e. IL-4 and IL-10 (25, 26) . The failure of T h 2 cells to induce IL-12 production by monocytes is interesting given that these cells are the major source of IL-12 in response to several infectious agents or their soluble products. However, whereas some of these pathogens, like Listeria monocytogenesor Toxoplasma gondii, directly activate monocytes for IL-12 production, others, like BCG or Mycobactehum avis, do it only if the monocytes have been preactivated with cytokines, mainly IFN-y (27, 28) . Similarly, activated T h 1/T h 0 cell clones induce IL-12 production by cytokine-activated but not by resting, freshly isolated monocytes (17) . The cytokines IFN-yand granulocyte macrophage colony stimulating factor prime monocytes for increased IL-12 production by enhancing the transcription of IL-12 p40 and p35 genes (29) (30) (31) as well as by up-regulating the expression of CD40 (32) , which is involved in T cellinduced IL-12 production by monocytes (17) . In complete agreement with the present observations on T h 2 cells, we recently observed that activated naive CD4 T cells induced IL-12 production by DC but not by resting monocytes (Y. Ohshima and G. Delespesse, unpublished observations). These findings that DC are more efficient than resting monocytes in producing IL-12 upon interaction with T cells, together with the fact that normal B cells (unlike Epstein-Barr virustransformed B cell lines) are poor IL-12 producers (16, 28) , suggest that DC are the main source of IL-12 when antigen is presented to T cells in neutral conditions. In other words, DC a$e likely to be responsible for the IL-12 produced in the course of an immune response to soluble protein antigens, that are devoid of adjuvant activity. Such a privileged role of DC is consistent with the fact that T cell-induced IL-12 production by APC is CD40-dependent (17, 20, 21) and that constitutive expression of CD40 is much higher on DC than on monocytes (32, 33) .
It is more and more accepted that the majority of T cells infiltrating inflammatory sites are non-antigen-specific and yet they contribute to the inflammation (34) . Such bystander T cells may be recruited and activated at the sites of T h 1-as well as T h 2-initiated responses. For example, after induction of experimental encephalomyelitis with a T cell clone specific for a peptide of myelin basic protein, the inflammatory infiltrate in the central nervous system contains a large number of T cells expressing unrelated and heterogenous antigen receptors (35) . Similarly, in allergic patients, the majority of T cell clones derived from positive allergen challenge sites are not specific for the allergen used to elicit the reaction (4, 36) . We have recently reported a mechanism that may account for the activation of bystander T cells (19, 20) . We showed that IL-2 induced non-cognate interactions between resting peripheral blood T cells and autologous APC (DC preparations) yielding to the production of proinflammatory molecules, including cytokines (IL-12, IL-1, IL-6, IL-8 and IFN-y) and prostaglandin E2. This in vitro inflammatory response was markedly enhanced by soluble CD23 and it was completely suppressed by blocking CD40-CD40L interactions (19, 20) . Here we have shown that IL-2 triggered similar interactions between T h 2 cells and APC, leading to the production of either IL-5 alone or IL-5 + IFN-y, depending upon whether T h 2 cells interacted with monocytes or DC respectively. The same levels of IL-5 were released in IL-2-stimulated cultures containing monocytes or DC and these were much higher (20-to 30-fold) than those observed in the absence of physiological APC. Thus, unlike CD32-B7 L cells, monocytes and DC both co-stimulated IL-5 production induced by IL-2, indicating that these cells provided a co-stimulatory signal distinct from B7-1.
The present observations provide a mechanism whereby at Pennsylvania State University on February 23, 2013 http://intimm.oxfordjournals.org/ Downloaded from non-antigen-specific T h 2 cells may be activated to produce the proinflammatory cytokines IL-5 and IFN-yat an inflammatory site where IL-2 is produced and thus contribute to maintain or amplify the inflammation. This might explain the clinical observation that airway infections trigger acute exacerbation of allergic asthma. The pathogen-specific T h 1/T h 0 cells infiltrating the airways may provide the adequate cytokine environment (IL-2) to activate allergen-specific T h 2 cells, that are known to infiltrate the bronchial mucosa of asthmatic patients. It is known that atopic dermatitis may be aggravated, and perhaps also perpetuated, by infection or chronic colonization of the skin by certain strains of Staphylococcus aureus, secreting superantigens (37) . Several observations suggested that these superantigens may penetrate the inflamed skin, bind to MHC class II bearing resident cells (i.e. mainly Langerhans cells, the cutaneous equivalent of the DC used in this study) and stimulate a large number of the T h 2 cells infiltrating the,skin of these patients (37) . Our finding that T h 2 cells respond to and induce IL-12 production by DC predict that S. aureus superantigens will activate the production of IFN-y in addition to IL-4 and IL-5. Indeed, in situ analysis of the cytokine mRNA or proteins expressed in lesional skin revealed that although IL-4 is predominantly expressed, the clinical course of the disease correlates with the expression of IFN-y rather than IL-4 (38) (39) (40) (41) . The present data also predict that circulating T h 2 cells that are randomly trapped at the site of a T h 1-mediated response, will be activated by IL-2 in an antigen-independent manner and release IL-5 or IL-5 + IFNy. Perhaps, this may contribute to explain the eosinophil infiltrates observed during some allograft rejections (42, 43) .
